vs
Side-by-side financial comparison of Goosehead Insurance, Inc. (GSHD) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Goosehead Insurance, Inc. is the larger business by last-quarter revenue ($93.1M vs $57.3M, roughly 1.6× RHYTHM PHARMACEUTICALS, INC.). Goosehead Insurance, Inc. runs the higher net margin — 8.6% vs -83.0%, a 91.6% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 23.1%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 9.2%).
Goosehead Insurance is a U.S.-based personal lines insurance agency that offers a wide range of coverage products including auto, home, renters, flood, and specialty insurance. It partners with hundreds of insurance carriers to provide clients with tailored, cost-effective coverage options, operating via corporate locations and a national franchise network for independent agents.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
GSHD vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $57.3M |
| Net Profit | $8.0M | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | 16.1% | -82.2% |
| Net Margin | 8.6% | -83.0% |
| Revenue YoY | 23.1% | 36.9% |
| Net Profit YoY | 204.0% | -9.6% |
| EPS (diluted) | $0.19 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $93.1M | — | ||
| Q4 25 | $105.3M | $57.3M | ||
| Q3 25 | $90.4M | $51.3M | ||
| Q2 25 | $94.0M | $48.5M | ||
| Q1 25 | $75.6M | $32.7M | ||
| Q4 24 | $93.9M | $41.8M | ||
| Q3 24 | $78.0M | $33.3M | ||
| Q2 24 | $78.1M | $29.1M |
| Q1 26 | $8.0M | — | ||
| Q4 25 | $12.4M | $-47.5M | ||
| Q3 25 | $7.9M | $-52.9M | ||
| Q2 25 | $5.2M | $-46.6M | ||
| Q1 25 | $2.3M | $-49.5M | ||
| Q4 24 | $14.9M | $-43.3M | ||
| Q3 24 | $7.6M | $-43.6M | ||
| Q2 24 | $6.2M | $-32.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
| Q1 26 | 16.1% | — | ||
| Q4 25 | 29.4% | -82.2% | ||
| Q3 25 | 23.5% | -102.6% | ||
| Q2 25 | 16.7% | -93.4% | ||
| Q1 25 | 8.8% | -143.7% | ||
| Q4 24 | 29.7% | -98.6% | ||
| Q3 24 | 21.1% | -132.0% | ||
| Q2 24 | 19.7% | -139.2% |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 11.8% | -83.0% | ||
| Q3 25 | 8.7% | -103.1% | ||
| Q2 25 | 5.5% | -96.1% | ||
| Q1 25 | 3.1% | -151.4% | ||
| Q4 24 | 15.8% | -103.6% | ||
| Q3 24 | 9.7% | -131.2% | ||
| Q2 24 | 7.9% | -110.9% |
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.48 | $-0.73 | ||
| Q3 25 | $0.29 | $-0.82 | ||
| Q2 25 | $0.18 | $-0.75 | ||
| Q1 25 | $0.09 | $-0.81 | ||
| Q4 24 | $0.58 | $-0.71 | ||
| Q3 24 | $0.29 | $-0.73 | ||
| Q2 24 | $0.24 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.7M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-121.3M | $139.1M |
| Total Assets | $392.8M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $25.7M | — | ||
| Q4 25 | $34.4M | $388.9M | ||
| Q3 25 | $51.6M | $416.1M | ||
| Q2 25 | $92.4M | $291.0M | ||
| Q1 25 | $70.2M | $314.5M | ||
| Q4 24 | $54.3M | $320.6M | ||
| Q3 24 | $47.5M | $298.4M | ||
| Q2 24 | $23.6M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $289.5M | — | ||
| Q3 25 | $290.0M | — | ||
| Q2 25 | $289.8M | — | ||
| Q1 25 | $290.3M | — | ||
| Q4 24 | $82.3M | — | ||
| Q3 24 | $84.6M | — | ||
| Q2 24 | $87.0M | — |
| Q1 26 | $-121.3M | — | ||
| Q4 25 | $-95.5M | $139.1M | ||
| Q3 25 | $-105.0M | $148.8M | ||
| Q2 25 | $-78.6M | $-11.9M | ||
| Q1 25 | $-88.5M | $18.9M | ||
| Q4 24 | $43.9M | $21.7M | ||
| Q3 24 | $58.3M | $11.2M | ||
| Q2 24 | $39.8M | $39.3M |
| Q1 26 | $392.8M | — | ||
| Q4 25 | $414.9M | $480.2M | ||
| Q3 25 | $403.6M | $506.9M | ||
| Q2 25 | $436.6M | $372.7M | ||
| Q1 25 | $412.6M | $386.7M | ||
| Q4 24 | $397.7M | $392.3M | ||
| Q3 24 | $358.1M | $363.6M | ||
| Q2 24 | $338.2M | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.87× | — | ||
| Q3 24 | 1.45× | — | ||
| Q2 24 | 2.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $91.8M | $-25.4M | ||
| Q3 25 | $24.2M | $-26.6M | ||
| Q2 25 | $28.9M | $-23.3M | ||
| Q1 25 | $15.5M | $-40.4M | ||
| Q4 24 | $71.5M | $-18.8M | ||
| Q3 24 | $28.1M | $-25.2M | ||
| Q2 24 | $18.9M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $86.1M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $27.2M | — | ||
| Q1 25 | $14.9M | — | ||
| Q4 24 | $70.6M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $18.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 81.8% | — | ||
| Q3 25 | 26.2% | — | ||
| Q2 25 | 28.9% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 75.1% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 23.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.38× | — | ||
| Q3 25 | 3.06× | — | ||
| Q2 25 | 5.61× | — | ||
| Q1 25 | 6.61× | — | ||
| Q4 24 | 4.82× | — | ||
| Q3 24 | 3.72× | — | ||
| Q2 24 | 3.05× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSHD
| Renewal Royalty Fees (2) | $43.6M | 47% |
| Renewal Commissions (1) | $18.2M | 20% |
| Contingent Commissions (1) | $10.7M | 11% |
| New Business Royalty Fees (2) | $7.9M | 8% |
| New Business Commissions (1) | $7.5M | 8% |
| Other | $3.7M | 4% |
| Initial Franchise Fees (2) | $1.6M | 2% |
RYTM
Segment breakdown not available.
